TSHA

Taysha Gene Therapies Inc. Common Stock (TSHA)

Stock · NASDAQ · Health Care

$5.77as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$4.49
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Taysha Gene Therapies Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • TSHA
    Taysha Gene Therapies Inc. Common Stock
    $5.77
    ▼ 3.19%
    Market cap $1.82BP/E
  • RXRX
    Recursion Pharmaceuticals Inc. Class A Common Stock
    $3.33
    ▼ 3.20%
    Market cap $1.69BP/E
    $2.77$7.18
  • MESO
    Mesoblast Limited American Depositary Shares
    $17.42
    ▼ 4.18%
    Market cap $2.02BP/E
    $1.88$3.31
  • VIR
    Vir Biotechnology Inc. Common Stock
    $10.83
    ▼ 4.24%
    Market cap $1.48BP/E
  • GLUE
    Monte Rosa Therapeutics Inc. Common Stock
    $13.37
    ▼ 6.63%
    Market cap $1.33BP/E
    $4.6$25.77
  • VOR
    Vor Biopharma Inc. Common Stock
    $22.66
    ▼ 3.70%
    Market cap $1.28BP/E
    $6.5$49.95
  • NVAX
    Novavax Inc. Common Stock
    $9.27
    ▲ 2.43%
    Market cap $1.27BP/E

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
261.44M
Total value held
$1.18B
Institutional holders
187
Top holders this quarter
  • Unknown23.56M
  • Unknown22.37M
  • Unknown21.70M
  • Unknown18.37M
  • Unknown18.00M
  • Unknown17.97M
  • Unknown14.32M
  • Unknown13.68M
  • Unknown11.21M
  • Unknown10.23M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.